2010 Metals in Medicine Gordon Research Conference

2010 年戈登医学金属研究会议

• 批准号: 7906374
• 负责人: DEBBIE Catharina CRANS
• 金额: $ 0.7万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-15 至 2011-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7906374
• 关键词: Academy; Advertisements; Aging; Area; Arsphenamine; Arts; Basic Science; Biochemistry; Biology; Cardiovascular system; Child; Cisplatin; Clinic; Clinical; Collaborations; Contrast Media; Development; Diagnostic Imaging; Discipline of Nuclear Medicine; Disease; Environment; Fostering; Hospitals; Image; Inorganic Chemistry; Laboratories; Learning; Magnetic Resonance Imaging; Medicine; Metabolic Diseases; Metals; Nationalities; Neurodegenerative Disorders; Patients; Pharmaceutical Preparations; Pharmacists; Physicians; Physicians' Offices; Plant Roots; Platinum; Radiopharmaceuticals; Research; Research Personnel; Scientist; Students; Text; Time; Update; Work; abstracting; base; clinical practice; drug development; fighting; meetings; multidisciplinary; nanoscience; novel; novel strategies; oncology; pre-clinical; public health relevance; skills; success; symposium

DESCRIPTION (provided by applicant): Advertisements often found in the local physician's office, depicting a small child in a cold world with the text "this child has a drug problem" is documenting how much need there is for unconventional approaches to fight disease today. Indeed, the Gordon Research conference "Metals in Medicine: Medicinal Inorganic Chemistry" is spearheading just this cause. Solidly rooted in the area of oncology where cisplatin and other platinum drugs have documented the success of metal-based drugs, other areas are still hopefully waiting for similar discoveries. However, with many new approaches the search continues fueled by the past successes, such as Paul Ehrlich's anti-syphilitic agent arsphenamine (Salvarsan). Importantly, the researchers and clinicians need a common forum where information and strategies can be shared. To this end the fertile environment upon which discoveries can be born must be created. The Metals in Medicine Gordon Research Conference will be held at Proctor Academy, NH, June 27-July 2nd, 2010. This meeting will feature a broad range of presentations from a diverse group of speakers from different backgrounds and of different Nationalities. In addition, the mix will include senior level investigators, as well as beginning investigators and student presenters. For the first time in this conference a significant fraction of young scientist presentations will be selected from the submitted abstracts and on an experimental basis thus provide a forum for the students and young and beginning scientists to learn and develop key skills to develop new treatments of disease. We believe that the addition of this new type of presentation is important to our area and can help foster partnerships and collaborations and the development of the drug and treatments of tomorrow. Such an approach will allow a format to update those in the area what is successful in the clinic, as well as the laboratory in the battle of diseases. At the Metals in Medicine Gordon Conference we have the opportunity to bring together a group of interdisciplinary scientists and physicians to share and learn from inorganic chemistry, to biochemistry, biology and medicine in preclinical development and to treatment of patients in an experimental or hospital-type setting. At this meeting we will cover the following seven health-related areas: Oncology, Diagnostics/Imaging, Nuclear Medicine, Infectious and Neurodegenerative Diseases, Metabolic Disorders, Cardiovascular Malady, and Aging. PUBLIC HEALTH RELEVANCE: The Gordon Research Conference Metals in Medicine is a multidisciplinary meeting, in which chemists, biochemists, biologist, pharmacist and clinicians come together to learn the state-of-the-art in both basic sciences and clinical work. Metals in Medicine is a rapidly developing field documented with several key drugs, such as cisplatin in oncology, MRI contrast agents, Cardiolyte radiopharmaceutical imaging agents and nanoscience applications. These novel and unconventional approaches to fighting disease require multidisciplinary connectivity to validate the results needed by researchers to develop in laboratories and clinical settings alike. The meeting will feature both current clinical practices and discovery-level research in the following seven health-related areas: Oncology, Diagnostics/Imaging, Nuclear Medicine, Infectious and Neurodegenerative Diseases, Metabolic Disorders, Cardiovascular Malady, and Aging.

描述（由申请人提供）：当地医生办公室经常出现的广告，描绘了一个寒冷世界中的小孩，并附有文字“这个孩子有毒品问题”，这表明当今对抗疾病的非传统方法有多么需要。事实上，戈登研究会议“医学中的金属：药用无机化学”正是这一事业的带头人。顺铂和其他铂类药物扎根于肿瘤学领域，已经证明了金属药物的成功，但其他领域仍有望等待类似的发现。然而，在过去的成功的基础上，许多新方法的研究仍在继续，例如保罗·埃利希的抗梅毒药物胂凡那明（Salvarsan）。重要的是，研究人员和临床医生需要一个可以共享信息和策略的共同论坛。为此，必须创造孕育新发现的肥沃环境。 戈登医学金属研究会议将于 2010 年 6 月 27 日至 7 月 2 日在新罕布什尔州普罗克特学院举行。这次会议将由来自不同背景和不同国籍的不同演讲者进行广泛的演讲。此外，该组合还将包括高级研究人员、初级研究人员和学生演示者。本次会议将首次从提交的摘要中挑选出相当一部分年轻科学家的演讲，并以实验为基础，从而为学生和年轻科学家提供一个学习和发展关键技能以开发新的疾病治疗方法的论坛。我们相信，这种新型演示的增加对我们的领域很重要，可以帮助促进伙伴关系和合作以及未来药物和治疗方法的开发。这种方法将允许一种格式来更新那些在临床和实验室在疾病斗争中取得成功的领域。 在戈登医学金属会议上，我们有机会聚集一群跨学科的科学家和医生，分享和学习无机化学、临床前开发中的生物化学、生物学和医学，以及在实验或医院类型环境中对患者的治疗。在本次会议上，我们将涵盖以下七个与健康相关的领域：肿瘤学、诊断/成像、核医学、传染病和神经退行性疾病、代谢紊乱、心血管疾病和衰老。 公共健康相关性：戈登医学金属研究会议是一次多学科会议，化学家、生物化学家、生物学家、药剂师和临床医生齐聚一堂，学习基础科学和临床工作的最新技术。医学中的金属是一个快速发展的领域，记录了多种关键药物，例如肿瘤学中的顺铂、MRI 造影剂、Cardiolyte 放射性药物成像剂和纳米科学应用。这些对抗疾病的新颖且非常规的方法需要多学科的联系来验证研究人员在实验室和临床环境中开发所需的结果。会议将重点介绍以下七个健康相关领域的当前临床实践和发现级研究：肿瘤学、诊断/成像、核医学、传染病和神经退行性疾病、代谢紊乱、心血管疾病和衰老。